source Post navigation Insurance Coverage For Ozempic, Zepbound Went Down In 2025 – Forbes Comparative Cardiovascular and Renal Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: A Systematic Review – Cureus